Giovanni Caforio

Giovanni Caforio

Director/Board Member at STRYKER CORPORATION

Net worth: 20 M $ as of 30/04/2024

59 year
Commercial Services
Health Technology
Consumer Services

Giovanni Caforio active positions

CompaniesPositionStartEnd
STRYKER CORPORATION Director/Board Member 01/12/2020 -
Independent Dir/Board Member 01/12/2020 -
Director/Board Member - -
Hun School of Princeton, Inc. Director/Board Member - -
Corporate Officer/Principal - -
Corporate Officer/Principal - -
Bristol-Myers Squibb Romania SRL Chief Executive Officer - -
Chairman - -

Career history of Giovanni Caforio

Former positions of Giovanni Caforio

CompaniesPositionStartEnd
BRISTOL-MYERS SQUIBB COMPANY Director/Board Member 05/06/2014 02/05/2017
Chief Executive Officer 05/05/2015 01/11/2023
Chairman 02/05/2017 01/04/2024
Chief Operating Officer 05/06/2014 05/05/2015
Corporate Officer/Principal 01/05/2004 05/06/2014
President 05/06/2014 05/05/2015
Director/Board Member 16/06/2015 31/01/2019
Chairman 31/01/2019 09/12/2020
Treasurer 16/06/2015 31/01/2019
Abbott Laboratórios Lda. Corporate Officer/Principal 01/01/1988 01/01/2000
░░░ ░░░░░░░░░░ ░░ ░░░░░░░ ░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ - -
░░░░░░░░ ░░░░░░░░░░░░░░ ░░░░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░ -
░░░░░░░ ░░░░░░ ░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ - -

Training of Giovanni Caforio

Università degli Studi di Roma Tor Vergata Doctorate Degree

Statistics

International

United States 10
Portugal 2
Italy 2

Operational

Director/Board Member 7
Corporate Officer/Principal 5
Chairman 3

Sectoral

Commercial Services 6
Health Technology 4
Consumer Services 3

Positions held

Active

Inactive

Listed companies

Private companies

Linked companies

Listed companies2
BRISTOL-MYERS SQUIBB COMPANY

Health Technology

STRYKER CORPORATION

Health Technology

Private companies9

Health Services

Commercial Services

Abbott Laboratórios Lda.

Health Technology

Commercial Services

Commercial Services

Commercial Services

Commercial Services

Bristol-Myers Squibb Romania SRL

See company connections
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW